Vreni Schoenenberger
InvestorExpert in Residence at Imperial College London
New York, New York
Writes $250K – $1M checks · typically $500K
Find your path to Vreni
1,267 people in our graph share verified history with Vreni — schools, employers, funds. One of them is your warm intro.
Katrin GeyskensunlockedVreni: together at Icometrix (2023–2025)
Vreni: together at Yale University
×9Vreni: together at Imperial College London
Vreni: together at U.S. Department of State
About
Vreni Schoenenberger is a healthcare executive with over 15 years of experience in external affairs and partnership development across pharmaceutical, biotech, and venture capital sectors. She has held roles involving market strategy, commercial launches, and stakeholder engagement at major pharma companies and smaller biotech firms, with particular expertise in neurology, rare disease, gene therapy, and oncology. Schoenenberger holds a Ph.D. from Yale and is a Fulbright Scholar; she currently serves as an advisor and board director.
Experience
- People & RobotsAdvisorcurrent2024 — present
- Array InsightsAdvisorcurrent2024 — present
- Valink TherapeuticsAdvisorcurrent2023 — presentSan Francisco Bay Area
- Imperial College LondonExpert in Residencecurrent2023 — present
- Hypervision SurgicalAdvisorcurrent2022 — present
- icometrixStrategic Advisory Board Membercurrent2023 — present
- RA Capital ManagementManaging Director2024 — 2026Boston, MA
- NovartisGlobal Head, External Affairs and Partnerships (Commercial Development)2021 — 2024Basel, Switzerland; East Hanover, NJ
- NovartisGlobal Executive Director, Global Head Of Public Affairs, Neuroscience2017 — 2021Basel
- NovartisGlobal Head of Strategy & Operations (Sandoz)2016 — 2017Greater Munich Metropolitan Area
- Ada VenturesVenture Scout2021 — 2024
- University of OxfordMentor2020 — 2024Oxford
- European Brain CouncilBoard Member2019 — 2024Brussels, Brussels Region, Belgium
- Imperial Enterprise LabHealthtrack Sponsor and Mentor2022 — 2024
- MindstepBoard Advisor2022 — 2024
- OKKO HealthNon Executive Director2021 — 2024
- NeuronosticsBoard Advisor2022 — 2023
- IFPMAManager, Policy, Ethics and Compliance2015 — 2016Geneva Area, Switzerland
- DuPont Sustainable SolutionsExternal Consultant2012 — 2014Wilmington, Delaware, United States
- U.S. Department of StateFulbright Scholar, Switzerland2010 — 2011Geneva, Switzerland
- Yale UniversityTeaching Fellow2009 — 2011Department of History / School of Medicine / School of Law
- Yale UniversityProgram Officer, Yale Office of Development (Yale endowment)2008 — 2011New Haven, CT
- Yale-New Haven HospitalClinical Trial Oversight, Pulmonary Medicine2008
.jpeg){kind=logo}
Skills & more
Policy Analysis22Public Affairs11Pharmaceutical Industry10PharmaceuticalsStrategy8Research12Public Health7Health Policy6Project Management2Corporate Governance4Corporate Social Responsibility2History2
+8 more
Food IndustryGrant WritingScienceGovernmentNeuroscienceTeachingPublic-private PartnershipsFood PolicyLanguages English · French
From Vreni's professional profile.
Colleagues at Imperial College London
Adam Stokes
Academic in Residence at Archangels
Andrea Bonaceto
Partner at Eterna Capital
Anna Tchorzewska
Associate at Kurma Partners
Brittany Barreto
General Partner at Coyote Ventures
Claudia Marcusson
Advisor at Urban Impact Ventures
Cornelia Gomez
Managing Director at General Atlantic
Dr. Manmit Bhambra
Senior DEI Advisor at PACE Healthcare Capital
Edwin Appiah
General Partner at Cornerstone VC
Frequently asked questions
- Who is Vreni Schoenenberger?
- Vreni Schoenenberger is a healthcare executive with over 15 years of experience in external affairs and partnership development across pharmaceutical, biotech, and venture capital sectors. She has held roles involving market strategy, commercial launches, and stakeholder engagement at major pharma companies and smaller biotech firms, with particular expertise in neurology, rare disease, gene therapy, and oncology. Schoenenberger holds a Ph.D. from Yale and is a Fulbright Scholar; she currently serves as an advisor and board director.
- Where does Vreni Schoenenberger work?
- Vreni Schoenenberger is Expert in Residence at Imperial College London.
- What check size does Vreni Schoenenberger write?
- Vreni Schoenenberger typically writes checks of $250K – $1M.
- Where did Vreni Schoenenberger go to school?
- Vreni Schoenenberger studied at Yale University (PhD, Modern History & Policy, Subfocus: Global Health, Business); Vanderbilt University (Bachelor of Science (B.S.), Bioethics); University of Melbourne (Bioethics/Medical Ethics).
Same school
Also attended Yale University966
Ann Miura-KoCo-founding Partner at FloodgateDavid SzeAdvisory Partner at GreylockMichael SeibelPartner Emeritus at Y CombinatorBen SilbermannCo-founder of PinterestZheela QaiserInvestor at Index VenturesAnthony PhilippakisInvestor at GV (Google Ventures)
+ 960 more
Also attended Vanderbilt University351
Jacob JofeInvestor at Index VenturesRoss Perot Jr.Chairman of The Perot Group at Perot JainDavid JohnsonManaging Director at Intel Capital, North AmericaTom DriscollPrincipal at Differential VenturesSabina SmithPrincipal at Scale Venture PartnersPayton DobbsOperating Partner at Hoxton Ventures
+ 345 more
Also attended University of Melbourne342
Cameron AdamsCo-founder & Chief Product Officer of CanvaKevin JohnsonInvestor at MedicxiEsther GilmoreGlobal Head of the Client Team at Generation Investment ManagementMark MillsClient Team Member at Generation Investment ManagementPaulInvestor at Square Peg CapitalClarissa KartikaAssociate, Investment at Vertex Ventures Sea Management Pte. Ltd.
:format(webp)/f/174198/3860x2650/d857c55b6f/steel-blue-clarissa.png)
+ 336 more
Shared employers
Also worked at Novartis201
Rebecca JamesInvestor at Index VenturesScott BillerInvestor at GV (Google Ventures)Freya Svedberg-KeatingInvestor at MedicxiAndrea AmadorCompliance Manager at Inveready Technology Investment GroupAbbie CelnikerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock Ventures
+ 195 more
%20(1).png)
